A method for quantitative evaluations of scanning-proton dose distributions
Bryce C Allred1, Jie Shan1, Daniel G Robertson1
1Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, USA.
Journal of Applied Clinical Medical Physics
|March 29, 2021
Summary
A new Patient-Specific Quality Assurance (PSQA) method, dose difference minimum (DDM), offers a more intuitive assessment of proton therapy dose planes. DDM provides comparable accuracy to the gamma test while better reflecting machine performance limits.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Quality Assurance
Background:
- Patient-Specific Quality Assurance (PSQA) is crucial for verifying the accuracy of radiation therapy dose calculations and delivery.
- The established gamma test is widely used but may not optimally parameterize errors for advanced techniques like proton therapy.
- Discrete spot scanning proton therapy allows for precise modulation of individual dose voxels, necessitating improved quality assurance metrics.
Purpose of the Study:
- To develop and evaluate a novel dose plane comparison approach for PSQA in proton therapy.
- To create a more intuitive error parameterization compared to the existing gamma test.
- To ensure the new method maintains the capabilities of the gamma test while improving relevance to machine performance.
Main Methods:
- A dose difference minimum (DDM) metric was developed, calculating the minimum dose deviation within a defined search radius for each pixel.
- Analysis involved 300 dose planes, comparing calculated points to measured pixels.
- The DDM metric was aggregated into histograms, and pass rates were determined based on a <3% dose difference criterion. Search radius was based on beamlet spatial deviation.
Main Results:
- The mean beamlet radial deviation was 0.38mm, with 99.9% of beams within 1mm of nominal.
- The DDM analysis (3%/1mm) showed a pass rate of 97.6% +/- 3.6%.
- This was comparable to the gamma test (3%/2mm) pass rate of 97.7% +/- 3.2%, indicating similar agreement levels.
Conclusions:
- The DDM method, using a cylindrical search shape, is proposed as a more relevant metric for PSQA in proton therapy.
- DDM avoids false positives by considering machine performance limits, unlike gamma tests with overly restrictive spatial thresholds.
- This new algorithm provides a straightforward evaluation of plan quality by accepting pixels within the dose and search radius thresholds.


